Korro Bio Inc. (NASDAQ: KRRO)
$48.49
-3.8700 ( -7.39% ) 14.5K
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
Market Data
Open
$48.49
Previous close
$52.35
Volume
14.5K
Market cap
$440.19M
Day range
$47.59 - $52.24
52 week range
$14.00 - $97.91
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jun 21, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
4 | Insider transactions | 2 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
8-k | 8K-related | 14 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 04, 2024 |
3 | Insider transactions | 2 | May 14, 2024 |